Report of the 19th follow-up survey of primary liver cancer in Japan.

PubWeight™: 0.82^‹?›

🔗 View Article (PMID 26970231)

Published in Hepatol Res on March 01, 2016

Authors

Masatoshi Kudo¹, Namiki Izumi¹, Takafumi Ichida¹, Yonson Ku¹, Norihiro Kokudo¹, Michiie Sakamoto¹, Tadatoshi Takayama¹, Osamu Nakashima¹, Osamu Matsui¹, Yutaka Matsuyama¹

Author Affiliations

1: The Liver Cancer Study Group of Japan, c/o Department of Gastroenterology and Hepatology, Kindai University Faculty of Medicine, Osaka-Sayama, Osaka, Japan.

Articles citing this ↘

Characteristics of patients with liver cancer in the BioBank Japan project. J Epidemiol (2017) 0.78

Hepatitis B Virus X Protein and Hepatocarcinogenesis. Int J Mol Sci (2016) 0.76

Albumin-Bilirubin (ALBI) Grade as Part of the Evidence-Based Clinical Practice Guideline for HCC of the Japan Society of Hepatology: A Comparison with the Liver Damage and Child-Pugh Classifications. Liver Cancer (2017) 0.75

New Evidence and Perspectives on the Management of Hepatocellular Carcinoma with Portal Vein Tumor Thrombus. J Clin Transl Hepatol (2017) 0.75

Low Incidence of Lymph Node Metastasis After Resection of Hepatitis Virus-Related Intrahepatic Cholangiocarcinoma. World J Surg (2016) 0.75